S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AKYA Akoya BioSciences Inc

2.12

0.00 (0.00%)

Last Updated: 02:10:56

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Akoya BioSciences Charts.

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Akoya BioSciences Charts.

Akoya BioSciences Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (17 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (17 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (17 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (17 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 22 November 2024 (17 hours ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (1 week ago) • Edgar (US Regulatory)

Akoya Biosciences Reports Third Quarter 2024 Financial Results
Friday 15 November 2024 (1 week ago) • GlobeNewswire Inc.

Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel
Wednesday 6 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Monday 4 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
Monday 28 October 2024 (4 weeks ago) • GlobeNewswire Inc.

Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
Monday 7 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 4 October 2024 (2 months ago) • Edgar (US Regulatory)

More Akoya BioSciences Inc News Articles

National Australia Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions